BiOptic Inc. (6850.TWO)
TWD 44.0
(1.38%)
TWD 44.0
(1.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 65.03 Million TWD | -26.51% |
| 2022 | 88.91 Million TWD | 54.31% |
| 2021 | 57.37 Million TWD | 79.22% |
| 2020 | 32.09 Million TWD | 0.0% |
| 2019 | 7.12 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 16 Million TWD | -57.17% |
| 2023 FY | - TWD | -26.51% |
| 2023 Q4 | 37.35 Million TWD | 34.96% |
| 2023 Q2 | 27.68 Million TWD | -49.68% |
| 2022 FY | - TWD | 54.31% |
| 2022 Q4 | 55 Million TWD | 0.0% |
| 2021 FY | - TWD | 79.22% |
| 2020 FY | - TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 83.476% |
| Level Biotechnology Inc. | 98.7 Million TWD | 34.108% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 245.372% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 190.187% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 357.75% |
| GlycoNex Incorporation | -126.82 Million TWD | 151.281% |
| VBI | -6.97 Million TWD | 1032.846% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 145.261% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | -198.203% |
| Visgeneer Inc. | 973 Thousand TWD | -6584.275% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 119.158% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 93.055% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 34.856% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 106.562% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | 3844.272% |
| Enimmune corporation | -228.96 Million TWD | 128.405% |
| TaiRx, Inc. | -208.64 Million TWD | 131.171% |
| CHO Pharma, Inc. | -277.73 Million TWD | 123.418% |
| EirGenix Inc. | -664.4 Million TWD | 109.789% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 11.997% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 5.937% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 106.07% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 157.502% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | -86.687% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 204.326% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 347.293% |
| RBC Bioscience Corporation | 36.54 Million TWD | -77.957% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 109.53% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 297.049% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 218.434% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 84.999% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 240.641% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 466.907% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 162.769% |
| Neith Corporation | -33.61 Million TWD | 293.508% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 181.224% |
| NaviFUS Corp. | -55.79 Million TWD | 216.566% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | 491.842% |
| Sinew Pharma Inc. | -163.63 Million TWD | 139.747% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 205.753% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 66.197% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 128.692% |
| AP Biosciences Inc | -325.51 Million TWD | 119.98% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 106.226% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 281.437% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | -123.268% |
| Intech Biopharm Corporation | -219.58 Million TWD | 129.619% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 109.646% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 244.686% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 140.432% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 90.078% |
| TCI GENE Inc. | 25.98 Million TWD | -150.329% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 158.785% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 122.918% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 144.556% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | -369.588% |
| PharmaEngine, Inc. | 347.3 Million TWD | 81.274% |
| Savior Lifetec Corporation | 219.6 Million TWD | 70.384% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 62.238% |
| OBI Pharma, Inc. | -855.08 Million TWD | 107.606% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 170.263% |
| Acepodia, Inc. | -764.51 Million TWD | 108.507% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 114.136% |